Price Alert

Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · Real-Time Price · USD

1.32

-0.02 (-1.49%)

At close: Aug 15, 2025, 3:07 PM

Cardiol Therapeutics Balance Sheet Statement

Financials in CAD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	23.29M	30.58M	15.89M	24.02M	28.57M	34.87M	40.54M	44.94M	49.47M	59.47M	65.53M	70.45M	74.84M	83.9M	28.65M	32.72M	18M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	61.88K	61.88K	61.88K	61.88K	61.88K	61.57K	n/a	61.57K	61.57K	61.51K	61.51K	61.51K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	n/a	n/a	n/a	n/a	n/a
Receivables	346.69K	361.62K	266.71K	n/a	317.11K	n/a	n/a	n/a	408.16K	n/a	154.12K	403.62K	486K	407.13K	385.37K	113.52K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	-289.6K	n/a	n/a	n/a	339.05K	339.05	339.05K	n/a	339.05K	339.05K	17.97K
Other Current Assets	n/a	n/a	n/a	n/a	n/a	279.87K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	25.27M	31.67M	17.28M	25.88M	30.64M	36.15M	42.45M	46.65M	52.11M	61.44M	67.76M	73.62M	78.73M	87.14M	30.94M	35.92M	20.21M
Property-Plant & Equipment	182.54K	195.59K	237.93K	263.01K	300.01K	337.06K	372K	269.29K	302.78K	295.74K	284.83K	308.91K	339.45K	356.49K	390.97K	412.54K	446.05K
Goodwill & Intangibles	n/a	n/a	n/a	168.14K	189.25K	210.36K	231.47K	252.58K	273.69K	294.8K	315.91K	337.02K	358.13K	379.25K	400.36K	421.47K	442.58K
Total Long-Term Assets	182.54K	195.59K	237.93K	431.14K	489.25K	547.41K	603.47K	521.87K	576.47K	590.54K	600.74K	645.93K	697.58K	735.74K	791.33K	834K	888.62K
Total Assets	25.45M	31.86M	17.52M	26.31M	31.13M	36.7M	43.05M	47.17M	52.69M	62.03M	68.36M	74.26M	79.43M	87.88M	31.73M	36.75M	21.1M
Account Payables	7.72M	6.98M	6.92M	9.43M	8.44M	7.62M	6.91M	6.68M	5.94M	8.35M	6.91M	6.72M	4.94M	4.14M	1.74M	2.21M	2.18M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-7.62M	280.33K	-6.68M	-5.94M	-8.35M	-6.92M	-6.72M	-4.95M	-4.19M	-1.74M	-2.21M	-2.18M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	-280.33K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	3.65K	1.36M	2.05M	238.18K	529.5K	1.2M	345.82K	419.9K	1.94M	3.67M	4.53M	6.66M	n/a	n/a	0.00
Total Current Liabilities	7.75M	7.01M	6.95M	10.81M	10.92M	8.3M	8.03M	8.42M	7.12M	9.8M	9.65M	11.37M	10.16M	11.57M	2.57M	2.93M	2.76M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	116.41K	125.52K	134.2K	142.55K	150.66K	158.53K	152.14K	n/a	9.09K	22.42K	35.45K	48.19K	60.66K	72.87K	74.56K	85.25K	95.19K
Total Liabilities	7.87M	7.14M	7.09M	10.95M	11.07M	8.45M	8.18M	8.42M	7.13M	9.83M	9.68M	11.41M	10.22M	11.64M	2.65M	3.01M	2.86M
Total Debt	150.66K	158.53K	165.98K	164.27K	167.14K	174.34K	181.21K	48.19K	60.66K	72.87K	84.77K	96.4K	107.24K	117.58K	127.63K	137.46K	147.1K
Common Stock	179.34M	179.34M	154.63M	152.35M	151.09M	148.52M	147.77M	147.67M	147.63M	147.55M	146.93M	143.14M	143.05M	142.92M	89.83M	85.53M	67.75M
Retained Earnings	-187.54M	-179.25M	-171.7M	-158.35M	-151.76M	-142.58M	-134.94M	-129.01M	-121.54M	-114.45M	-106.93M	-98.96M	-92.47M	-83.52M	-77.26M	-67.35M	-60.79M
Comprehensive Income	n/a	n/a	n/a	n/a	3.52M	3.52M	3.52M	3.52M	3.52M	3.52M	3.52M	5.53M	4.91M	4.18M	4.32M	5.09M	1.55M
Shareholders Equity	17.59M	24.73M	10.43M	15.36M	20.06M	28.25M	34.87M	38.75M	45.56M	52.2M	58.68M	62.85M	69.21M	76.24M	29.09M	33.74M	18.24M
Total Investments	n/a	n/a	n/a	n/a	n/a	61.88K	61.88K	61.88K	61.88K	61.88K	61.57K	n/a	61.57K	61.57K	61.51K	61.51K	61.51K